Literature DB >> 23753224

Subsequent infections in survivors of sepsis: epidemiology and outcomes.

Tisha Wang1, Ariss Derhovanessian, Sharon De Cruz, John A Belperio, Jane C Deng, Guy Soo Hoo.   

Abstract

PURPOSE: Sepsis is a devastating condition with considerable mortality. The causes of long-term mortality are poorly understood. To test the hypothesis that patients with sepsis are more susceptible to recurrent infections and death due to infectious complications, we investigated the outcomes of patients who survived sepsis, with regard to the incidence of recurrent infections and mortality.
MATERIALS AND METHODS: A retrospective study of the patients admitted to the intensive care unit (ICU) for sepsis from 2001 to 2002 who achieved 30-day survival (sepsis survivors [SSs], N = 78) and a control group of patients admitted to the ICU for noninfectious conditions with a similar severity of illness (N = 50) was performed. The primary end point was the number of recurrent infections in the first year posthospitalization.
RESULTS: The SSs group had higher rates of infections following hospital discharge compared to controls. Using a multivariable model, having survived sepsis was the strongest predictor of the development of subsequent infections (rate ratio [RR]: 2.83, P= .0006), the need for rehospitalization for infection in the year after the initial hospitalization (RR: 3.78, P = .0009), and postdischarge mortality (hazard ratio = 3.61, P = .003).
CONCLUSIONS: Critically ill patients who survive sepsis have an increased risk of recurrent infections in the year following their septic episode that is associated with increased mortality.

Entities:  

Keywords:  immunosuppression; outcomes; sepsis

Mesh:

Year:  2012        PMID: 23753224      PMCID: PMC4393330          DOI: 10.1177/0885066612467162

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  20 in total

Review 1.  Severity of illness scoring systems in the intensive care unit.

Authors:  Mark T Keegan; Ognjen Gajic; Bekele Afessa
Journal:  Crit Care Med       Date:  2011-01       Impact factor: 7.598

Review 2.  Transfusion immunomodulation or TRIM: what does it mean clinically?

Authors:  M A Blajchman
Journal:  Hematology       Date:  2005       Impact factor: 2.269

3.  Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M.

Authors:  Jane C Deng; Genhong Cheng; Michael W Newstead; Xianying Zeng; Koichi Kobayashi; Richard A Flavell; Theodore J Standiford
Journal:  J Clin Invest       Date:  2006-08-17       Impact factor: 14.808

Review 4.  Mechanisms of transfusion-associated immunosuppression.

Authors:  M A Blajchman; J O Bordin
Journal:  Curr Opin Hematol       Date:  1994-11       Impact factor: 3.284

5.  Immunosuppression in patients who die of sepsis and multiple organ failure.

Authors:  Jonathan S Boomer; Kathleen To; Kathy C Chang; Osamu Takasu; Dale F Osborne; Andrew H Walton; Traci L Bricker; Stephen D Jarman; Daniel Kreisel; Alexander S Krupnick; Anil Srivastava; Paul E Swanson; Jonathan M Green; Richard S Hotchkiss
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

6.  One-year mortality of bloodstream infection-associated sepsis and septic shock among patients presenting to a regional critical care system.

Authors:  Kevin B Laupland; David A Zygun; Christopher J Doig; Sean M Bagshaw; Lawrence W Svenson; Gordon H Fick
Journal:  Intensive Care Med       Date:  2005-01-22       Impact factor: 17.440

Review 7.  Long-term mortality and quality of life in sepsis: a systematic review.

Authors:  Bradford D Winters; Michael Eberlein; Janice Leung; Dale M Needham; Peter J Pronovost; Jonathan E Sevransky
Journal:  Crit Care Med       Date:  2010-05       Impact factor: 7.598

8.  Long-term outcome and quality-adjusted life years after severe sepsis.

Authors:  Sari Karlsson; Esko Ruokonen; Tero Varpula; Tero I Ala-Kokko; Ville Pettilä
Journal:  Crit Care Med       Date:  2009-04       Impact factor: 7.598

Review 9.  Molecular and cellular aspects of sepsis-induced immunosuppression.

Authors:  Tisha S Wang; Jane C Deng
Journal:  J Mol Med (Berl)       Date:  2008-02-08       Impact factor: 4.599

10.  RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis.

Authors:  Eric A J Hoste; Gilles Clermont; Alexander Kersten; Ramesh Venkataraman; Derek C Angus; Dirk De Bacquer; John A Kellum
Journal:  Crit Care       Date:  2006-05-12       Impact factor: 9.097

View more
  41 in total

1.  Hospital-based acute care use in survivors of septic shock.

Authors:  Alexandra Ortego; David F Gaieski; Barry D Fuchs; Tiffanie Jones; Scott D Halpern; Dylan S Small; S Cham Sante; Byron Drumheller; Jason D Christie; Mark E Mikkelsen
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

2.  Post-Acute Care Use and Hospital Readmission after Sepsis.

Authors:  Tiffanie K Jones; Barry D Fuchs; Dylan S Small; Scott D Halpern; Asaf Hanish; Craig A Umscheid; Charles A Baillie; Meeta Prasad Kerlin; David F Gaieski; Mark E Mikkelsen
Journal:  Ann Am Thorac Soc       Date:  2015-06

3.  Recent Anti-Microbial Exposure Is Associated with More Complications after Elective Surgery.

Authors:  Christopher A Guidry; Puja M Shah; Zachary C Dietch; Nathan R Elwood; Elizabeth D Krebs; J Hunter Mehaffey; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2018-06-08       Impact factor: 2.150

4.  Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis.

Authors:  Jacqueline G O'Leary; K Rajender Reddy; Florence Wong; Patrick S Kamath; Heather M Patton; Scott W Biggins; Michael B Fallon; Guadalupe Garcia-Tsao; Ram M Subramanian; Raza Malik; Leroy R Thacker; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-12       Impact factor: 11.382

5.  Impairment of osmotic challenge-induced neurohypophyseal hormones secretion in sepsis survivor rats.

Authors:  Nilton Nascimento Santos-Junior; Luís Henrique Angenendt Costa; Carlos Henrique Rocha Catalão; Alexandre Kanashiro; Tarek Sharshar; Maria José Alves Rocha
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

6.  Bone marrow is the preferred site of memory CD4+ T cell proliferation during recovery from sepsis.

Authors:  Tomasz Skirecki; Patrycja Swacha; Grażyna Hoser; Jakub Golab; Dominika Nowis; Ewa Kozłowska
Journal:  JCI Insight       Date:  2020-05-21

7.  Ultralow doses of dextromethorphan protect mice from endotoxin-induced sepsis-like hepatotoxicity.

Authors:  Ran Zhou; Shih-Heng Chen; Guorong Li; Hui-Ling Chen; YuXin Liu; Hung-Ming Wu; Yubao Wang; Jing Feng; Jau-Shyong Hong
Journal:  Chem Biol Interact       Date:  2019-02-26       Impact factor: 5.192

8.  Readmissions for Recurrent Sepsis: New or Relapsed Infection?

Authors:  Kimberley Marie DeMerle; Stephanie C Royer; Mark E Mikkelsen; Hallie C Prescott
Journal:  Crit Care Med       Date:  2017-10       Impact factor: 7.598

9.  Increased healthcare facility use in veterans surviving sepsis hospitalization.

Authors:  Kimberley M DeMerle; Brenda M Vincent; Theodore J Iwashyna; Hallie C Prescott
Journal:  J Crit Care       Date:  2017-07-03       Impact factor: 3.425

Review 10.  Sepsis 2019: What Surgeons Need to Know.

Authors:  Vanessa P Ho; Haytham Kaafarani; Rishi Rattan; Nicholas Namias; Heather Evans; Tanya L Zakrison
Journal:  Surg Infect (Larchmt)       Date:  2019-11-22       Impact factor: 2.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.